廣告
香港股市 將在 3 小時 53 分鐘 開市
  • 恒指

    18,537.81
    +223.91 (+1.22%)
     
  • 國指

    6,560.67
    +103.95 (+1.61%)
     
  • 上證綜指

    3,154.32
    +25.84 (+0.83%)
     
  • 道指

    39,387.76
    +331.37 (+0.85%)
     
  • 標普 500

    5,214.08
    +26.41 (+0.51%)
     
  • 納指

    16,346.26
    +43.46 (+0.27%)
     
  • Vix指數

    12.69
    -0.31 (-2.38%)
     
  • 富時100

    8,381.35
    +27.30 (+0.33%)
     
  • 紐約期油

    79.26
    +0.27 (+0.34%)
     
  • 金價

    2,340.30
    +18.00 (+0.78%)
     
  • 美元

    7.8140
    -0.0030 (-0.04%)
     
  • 人民幣

    0.9234
    -0.0002 (-0.02%)
     
  • 日圓

    0.0500
    -0.0000 (-0.04%)
     
  • 歐元

    8.4233
    +0.0230 (+0.27%)
     
  • Bitcoin

    62,574.39
    +1,003.05 (+1.63%)
     
  • CMC Crypto 200

    1,343.88
    +43.78 (+3.37%)
     

Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln

April 24 (Reuters) - Laboratory service provider Labcorp said on Wednesday it will acquire Softbank-backed Invitae Corp's assets auctioned through a voluntary bankruptcy protection process, a few months after the genetic test maker filed for bankruptcy.

Labcorp will acquire all of the bankrupt firm's assets on a going concern basis for $239 million in cash consideration and other non-cash consideration, the companies said in separate statements.

In February, Invitae filed for voluntary Chapter 11 protection in a U.S. bankruptcy court and said that it intended to pursue a sale process.

Invitae's estimated assets were in the $500 million - $1 billion range, while its liabilities were in the $1 billion - $10 billion range, according to the bankruptcy filing. (Reporting by Chandni Shah in Bengaluru; Editing by Mrigank Dhaniwala)